What Is the Survival Rate for Gallbladder Cancer?

Gallbladder cancer survival rates range from over 80% at Stage 0 to under 5% at Stage 4, based on SEER data. The five-year relative survival rate averages around 20% across all stages combined. Early detection makes the biggest difference in outcome, yet most cases get diagnosed late since symptoms rarely show up until the disease has already spread.

According to Dr. Sandeep Nayak, whose clinical practice focuses on advanced gastrointestinal cancer surgery, “gallbladder cancer survival comes down almost entirely to the stage at diagnosis, not the treatment center a patient picks.”

Several clinical factors decide how gallbladder cancer behaves and how far it can be pushed back.

• Tumor Stage — Stage is the strongest predictor, since a cancer confined to the gallbladder wall behaves nothing like one that has already reached the liver or lymph nodes.
• Resectability — Whether the tumor can be completely removed with clear margins decides more than almost anything else here, and inoperable cases carry a far steeper drop in survival.
• Lymph Node Spread — Node involvement changes the picture fast, even a single positive node can pull five-year survival down by half or more.
• Incidental Detection — A fair number of cases turn up incidentally during routine gallstone surgery, and these tend to carry better outcomes simply because they’re caught earlier.

Gallbladder cancer sits within the broader family of biliary cancers, and treatment planning often overlaps with bile duct and pancreatic disease management. Getting an accurate stage before surgery isn’t optional, it’s the step that shapes everything after.

SEER data breaks gallbladder cancer survival down by how far the disease has spread at diagnosis.

• Localized Disease — Cancer confined to the gallbladder wall carries a five-year survival rate above 65%, and that number climbs even higher for the earliest, non-invasive Stage 0 tumors.
• Regional Spread — Once the disease reaches nearby organs or lymph nodes, survival drops to around 28%, a steep fall from localized numbers.
• Distant Metastasis — Metastatic gallbladder cancer, spread to the liver, lungs, or peritoneum, carries a five-year survival under 5%, and treatment shifts toward control rather than cure.
• Overall Average — Averaged across every stage combined, five-year survival sits close to 20%, though that figure hides how much stage at diagnosis actually matters.

Staging drives every decision that follows a gallbladder cancer diagnosis, much like it does with colon cancer, where the same stage-by-stage logic applies. A precise pathology report, not a general estimate, tells a patient where they actually stand.